← Evidence map

ArticleJournal of cancer research and clinical oncology2026

Glypican-1 targeted nanoplatform for pancreatic ductal adenocarcinoma: interpreting findings.

Arman Abroumand Gholami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42287441